195 related articles for article (PubMed ID: 20843722)
1. Methicillin-resistant Staphylococcus aureus: related infections and antibiotic resistance.
Stefani S; Goglio A
Int J Infect Dis; 2010 Oct; 14 Suppl 4():S19-22. PubMed ID: 20843722
[TBL] [Abstract][Full Text] [Related]
2. Ceftaroline pharmacodynamic activity versus community-associated and healthcare-associated methicillin-resistant Staphylococcus aureus, heteroresistant vancomycin-intermediate S. aureus, vancomycin-intermediate S. aureus and vancomycin-resistant S. aureus using an in vitro model.
Zhanel GG; Rossnagel E; Nichol K; Cox L; Karlowsky JA; Zelenitsky S; Noreddin AM; Hoban DJ
J Antimicrob Chemother; 2011 Jun; 66(6):1301-5. PubMed ID: 21429940
[TBL] [Abstract][Full Text] [Related]
3. Resistance or decreased susceptibility to glycopeptides, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus.
Nannini E; Murray BE; Arias CA
Curr Opin Pharmacol; 2010 Oct; 10(5):516-21. PubMed ID: 20598637
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of nasal carriage of methicillin-resistant Staphylococcus aureus and its antibiotic susceptibility pattern in healthcare workers at Namazi Hospital, Shiraz, Iran.
Askarian M; Zeinalzadeh A; Japoni A; Alborzi A; Memish ZA
Int J Infect Dis; 2009 Sep; 13(5):e241-7. PubMed ID: 19269873
[TBL] [Abstract][Full Text] [Related]
5. Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in nine USA hospitals.
Sader HS; Jones RN; Rossi KL; Rybak MJ
J Antimicrob Chemother; 2009 Nov; 64(5):1024-8. PubMed ID: 19744978
[TBL] [Abstract][Full Text] [Related]
6. [Comparative activity of daptomycin against clinical isolates of methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci].
Picazo JJ; Betriu C; Rodríguez-Avial I; Culebras E; López F; Gómez M;
Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):13-6. PubMed ID: 19406529
[TBL] [Abstract][Full Text] [Related]
7. Nationwide surveillance study of vancomycin intermediate Staphylococcus aureus strains in Korean hospitals from 2001 to 2006.
Chung G; Cha J; Han S; Jang H; Lee K; Yoo J; Yoo J; Kim H; Eun S; Kim B; Park O; Lee Ys
J Microbiol Biotechnol; 2010 Mar; 20(3):637-42. PubMed ID: 20372039
[TBL] [Abstract][Full Text] [Related]
8. Community-associated Staphylococcus aureus infections in children.
Rojo P; Barrios M; Palacios A; Gomez C; Chaves F
Expert Rev Anti Infect Ther; 2010 May; 8(5):541-54. PubMed ID: 20455683
[TBL] [Abstract][Full Text] [Related]
9. [Antimicrobial resistance of methicillin-resistant Staphylococcus aureus in hospital environment and inpatients].
Wu AH; Li CH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Oct; 30(5):525-30. PubMed ID: 19024378
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus and heterogeneously vancomycin-intermediate S. aureus in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations.
Leonard SN; Rybak MJ
J Antimicrob Chemother; 2009 Jan; 63(1):155-60. PubMed ID: 18984644
[TBL] [Abstract][Full Text] [Related]
11. [Antimicrobial susceptibility and resistance patterns of Staphylococcus aureus isolated from patients and carriers in Valdivia city, Chile].
Otth R L; Wilson Sch M; Bustamante H N; Fernández J H; Otth L C
Rev Chilena Infectol; 2008 Jun; 25(3):175-8. PubMed ID: 18580993
[TBL] [Abstract][Full Text] [Related]
12. [Antibiotic consumption and antimicrobial susceptibility evolution in the Centro Hospitalario Pereira Rossell in methicillin resistant Staphylococcus aureus era].
Telechea H; Speranza N; Lucas L; Santurio A; Giachetto G; Algorta G; Nanni L; Pírez MC
Rev Chilena Infectol; 2009 Oct; 26(5):413-9. PubMed ID: 19915749
[TBL] [Abstract][Full Text] [Related]
13. [Antibiotic susceptibility of Staphylococcus aureus strains isolated in two university hospitals in Rabat, Morocco].
Elhamzaoui S; Benouda A; Allali F; Abouqual R; Elouennass M
Med Mal Infect; 2009 Dec; 39(12):891-5. PubMed ID: 19269758
[TBL] [Abstract][Full Text] [Related]
14. Vancomycin heteroresistance and methicillin-resistant Staphylococcus aureus.
Deresinski S
J Infect Dis; 2009 Mar; 199(5):605-9. PubMed ID: 19199551
[No Abstract] [Full Text] [Related]
15. Recognition and management of infections caused by vancomycin-intermediate Staphylococcus aureus (VISA) and heterogenous VISA (hVISA).
Howden BP
Intern Med J; 2005 Dec; 35 Suppl 2():S136-40. PubMed ID: 16271057
[TBL] [Abstract][Full Text] [Related]
16. Heteroresistance to glycopeptides in Italian meticillin-resistant Staphylococcus aureus (MRSA) isolates.
Campanile F; Borbone S; Perez M; Bongiorno D; Cafiso V; Bertuccio T; Purrello S; Nicolosi D; Scuderi C; Stefani S
Int J Antimicrob Agents; 2010 Nov; 36(5):415-9. PubMed ID: 20727722
[TBL] [Abstract][Full Text] [Related]
17. Incidence and characteristics of vancomycin nonsusceptible strains of methicillin-resistant Staphylococcus aureus at Hershey Medical Center.
Kosowska-Shick K; Ednie LM; McGhee P; Smith K; Todd CD; Wehler A; Appelbaum PC
Antimicrob Agents Chemother; 2008 Dec; 52(12):4510-3. PubMed ID: 18838583
[TBL] [Abstract][Full Text] [Related]
18. MRSA--too many hurdles to overcome: a study from Central India.
Mallick SK; Basak S
Trop Doct; 2010 Apr; 40(2):108-10. PubMed ID: 20305109
[TBL] [Abstract][Full Text] [Related]
19. Clonal dissemination of meticillin-resistant and vancomycin-intermediate Staphylococcus aureus in a Taiwanese hospital.
Hsueh PR; Lee SY; Perng CL; Chang TY; Lu JJ
Int J Antimicrob Agents; 2010 Oct; 36(4):307-12. PubMed ID: 20685086
[TBL] [Abstract][Full Text] [Related]
20. Key considerations in the treatment of complicated staphylococcal infections.
Jones RN
Clin Microbiol Infect; 2008 Mar; 14 Suppl 2():3-9. PubMed ID: 18226084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]